Fast Company’s 11th annual Innovation Festival takes over New York City this September 15–18. Though every year introduces new offerings to the Innovation Festival, we’re also bringing back an ...
PTC518 was granted Fast Track designation based off strong 12-month interim data on safety and efficacy. The Food and Drug Administration (FDA) has granted Fast Track designation to PTC518 for the ...
Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...
The FDA has granted Regenerative Medicine Advanced Therapy designation to NouvNeu001, a cell therapy for Parkinson’s disease. NouvNeu001, developed by iRegene, is the first allogeneic cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results